{"id":56234,"date":"2023-04-26T13:07:50","date_gmt":"2023-04-26T11:07:50","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/deciphera-pharmaceuticals-to-announce-first-quarter-2023-financial-results-and-host-conference-call-and-webcast-on-may-3-2023\/"},"modified":"2023-04-26T13:07:50","modified_gmt":"2023-04-26T11:07:50","slug":"deciphera-pharmaceuticals-to-announce-first-quarter-2023-financial-results-and-host-conference-call-and-webcast-on-may-3-2023","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/deciphera-pharmaceuticals-to-announce-first-quarter-2023-financial-results-and-host-conference-call-and-webcast-on-may-3-2023\/","title":{"rendered":"Deciphera Pharmaceuticals to Announce First Quarter 2023 Financial Results and Host Conference Call and Webcast on May 3, 2023"},"content":{"rendered":"
\n

WALTHAM, Mass.–(BUSINESS WIRE)–Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH), a biopharmaceutical company focused on discovering, developing, and commercializing important new medicines to improve the lives of people with cancer, today announced that it will report its first quarter 2023 financial results on Wednesday, May 3, 2023.<\/p>\n

<\/a><\/p>\n

\nIn connection with the earnings release, Deciphera\u2019s management team will host a live conference call and webcast at 8:00 AM ET on Wednesday, May 3, 2023, to discuss the Company\u2019s financial results and provide a corporate update.<\/p>\n

\nThe conference call may be accessed via this link: https:\/\/register.vevent.com\/register\/BI75fb53c225a648b486e50d922b166468<\/a><\/p>\n

\nA live webcast of the conference call will be available in the \u201cEvents and Presentations\u201d page in the \u201cInvestors\u201d section of the Company\u2019s website at https:\/\/investors.deciphera.com\/events-presentations<\/a>. A replay will be available on the Company\u2019s website approximately two hours after the conference call and will be available for 30 days following the call.<\/p>\n

\nAbout Deciphera Pharmaceuticals<\/b><\/p>\n

\nDeciphera is a biopharmaceutical company focused on discovering, developing, and commercializing important new medicines to improve the lives of people with cancer. We are leveraging our proprietary switch-control kinase inhibitor platform and deep expertise in kinase biology to develop a broad portfolio of innovative medicines. In addition to advancing multiple product candidates from our platform in clinical studies, QINLOCK\u00ae is Deciphera\u2019s switch-control inhibitor for the treatment of fourth-line GIST. QINLOCK is approved in Australia, Canada, China, the European Union, Hong Kong, Israel, Macau, New Zealand, Switzerland, Taiwan, the United Kingdom, and the United States. For more information, visit www.deciphera.com<\/a> and follow us on LinkedIn and Twitter (@Deciphera).<\/p>\n

Contacts<\/b> <\/p>\n

\nInvestor Relations:<\/b>
Maghan Meyers
\n
Argot Partners
\n
Deciphera@argotpartners.com<\/a>
212-600-1902<\/p>\n

Media:<\/b>
David Rosen
\n
Argot Partners
\n
david.rosen@argotpartners.com<\/a>
212-600-1902<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

WALTHAM, Mass.–(BUSINESS WIRE)–Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH), a biopharmaceutical company focused on discovering, developing, and commercializing important new medicines to improve the lives of people with cancer, today announced that it will report its first quarter 2023 financial results on Wednesday, May 3, 2023. In connection with the earnings release, Deciphera\u2019s management team will host … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-56234","6":"format-standard","7":"category-industry"},"yoast_head":"\nDeciphera Pharmaceuticals to Announce First Quarter 2023 Financial Results and Host Conference Call and Webcast on May 3, 2023 - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/deciphera-pharmaceuticals-to-announce-first-quarter-2023-financial-results-and-host-conference-call-and-webcast-on-may-3-2023\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Deciphera Pharmaceuticals to Announce First Quarter 2023 Financial Results and Host Conference Call and Webcast on May 3, 2023 - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"WALTHAM, Mass.–(BUSINESS WIRE)–Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH), a biopharmaceutical company focused on discovering, developing, and commercializing important new medicines to improve the lives of people with cancer, today announced that it will report its first quarter 2023 financial results on Wednesday, May 3, 2023. In connection with the earnings release, Deciphera\u2019s management team will host ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/deciphera-pharmaceuticals-to-announce-first-quarter-2023-financial-results-and-host-conference-call-and-webcast-on-may-3-2023\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-04-26T11:07:50+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20230426005051\/en\/1562903\/21\/dcph-logo-registered-rgb.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/deciphera-pharmaceuticals-to-announce-first-quarter-2023-financial-results-and-host-conference-call-and-webcast-on-may-3-2023\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/deciphera-pharmaceuticals-to-announce-first-quarter-2023-financial-results-and-host-conference-call-and-webcast-on-may-3-2023\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Deciphera Pharmaceuticals to Announce First Quarter 2023 Financial Results and Host Conference Call and Webcast on May 3, 2023\",\"datePublished\":\"2023-04-26T11:07:50+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/deciphera-pharmaceuticals-to-announce-first-quarter-2023-financial-results-and-host-conference-call-and-webcast-on-may-3-2023\\\/\"},\"wordCount\":311,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/deciphera-pharmaceuticals-to-announce-first-quarter-2023-financial-results-and-host-conference-call-and-webcast-on-may-3-2023\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230426005051\\\/en\\\/1562903\\\/21\\\/dcph-logo-registered-rgb.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/deciphera-pharmaceuticals-to-announce-first-quarter-2023-financial-results-and-host-conference-call-and-webcast-on-may-3-2023\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/deciphera-pharmaceuticals-to-announce-first-quarter-2023-financial-results-and-host-conference-call-and-webcast-on-may-3-2023\\\/\",\"name\":\"Deciphera Pharmaceuticals to Announce First Quarter 2023 Financial Results and Host Conference Call and Webcast on May 3, 2023 - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/deciphera-pharmaceuticals-to-announce-first-quarter-2023-financial-results-and-host-conference-call-and-webcast-on-may-3-2023\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/deciphera-pharmaceuticals-to-announce-first-quarter-2023-financial-results-and-host-conference-call-and-webcast-on-may-3-2023\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230426005051\\\/en\\\/1562903\\\/21\\\/dcph-logo-registered-rgb.jpg\",\"datePublished\":\"2023-04-26T11:07:50+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/deciphera-pharmaceuticals-to-announce-first-quarter-2023-financial-results-and-host-conference-call-and-webcast-on-may-3-2023\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/deciphera-pharmaceuticals-to-announce-first-quarter-2023-financial-results-and-host-conference-call-and-webcast-on-may-3-2023\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/deciphera-pharmaceuticals-to-announce-first-quarter-2023-financial-results-and-host-conference-call-and-webcast-on-may-3-2023\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230426005051\\\/en\\\/1562903\\\/21\\\/dcph-logo-registered-rgb.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230426005051\\\/en\\\/1562903\\\/21\\\/dcph-logo-registered-rgb.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/deciphera-pharmaceuticals-to-announce-first-quarter-2023-financial-results-and-host-conference-call-and-webcast-on-may-3-2023\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Deciphera Pharmaceuticals to Announce First Quarter 2023 Financial Results and Host Conference Call and Webcast on May 3, 2023\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Deciphera Pharmaceuticals to Announce First Quarter 2023 Financial Results and Host Conference Call and Webcast on May 3, 2023 - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/deciphera-pharmaceuticals-to-announce-first-quarter-2023-financial-results-and-host-conference-call-and-webcast-on-may-3-2023\/","og_locale":"en_US","og_type":"article","og_title":"Deciphera Pharmaceuticals to Announce First Quarter 2023 Financial Results and Host Conference Call and Webcast on May 3, 2023 - Pharma Trend","og_description":"WALTHAM, Mass.–(BUSINESS WIRE)–Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH), a biopharmaceutical company focused on discovering, developing, and commercializing important new medicines to improve the lives of people with cancer, today announced that it will report its first quarter 2023 financial results on Wednesday, May 3, 2023. In connection with the earnings release, Deciphera\u2019s management team will host ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/deciphera-pharmaceuticals-to-announce-first-quarter-2023-financial-results-and-host-conference-call-and-webcast-on-may-3-2023\/","og_site_name":"Pharma Trend","article_published_time":"2023-04-26T11:07:50+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20230426005051\/en\/1562903\/21\/dcph-logo-registered-rgb.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/deciphera-pharmaceuticals-to-announce-first-quarter-2023-financial-results-and-host-conference-call-and-webcast-on-may-3-2023\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/deciphera-pharmaceuticals-to-announce-first-quarter-2023-financial-results-and-host-conference-call-and-webcast-on-may-3-2023\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Deciphera Pharmaceuticals to Announce First Quarter 2023 Financial Results and Host Conference Call and Webcast on May 3, 2023","datePublished":"2023-04-26T11:07:50+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/deciphera-pharmaceuticals-to-announce-first-quarter-2023-financial-results-and-host-conference-call-and-webcast-on-may-3-2023\/"},"wordCount":311,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/deciphera-pharmaceuticals-to-announce-first-quarter-2023-financial-results-and-host-conference-call-and-webcast-on-may-3-2023\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230426005051\/en\/1562903\/21\/dcph-logo-registered-rgb.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/deciphera-pharmaceuticals-to-announce-first-quarter-2023-financial-results-and-host-conference-call-and-webcast-on-may-3-2023\/","url":"https:\/\/pharma-trend.com\/en\/deciphera-pharmaceuticals-to-announce-first-quarter-2023-financial-results-and-host-conference-call-and-webcast-on-may-3-2023\/","name":"Deciphera Pharmaceuticals to Announce First Quarter 2023 Financial Results and Host Conference Call and Webcast on May 3, 2023 - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/deciphera-pharmaceuticals-to-announce-first-quarter-2023-financial-results-and-host-conference-call-and-webcast-on-may-3-2023\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/deciphera-pharmaceuticals-to-announce-first-quarter-2023-financial-results-and-host-conference-call-and-webcast-on-may-3-2023\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230426005051\/en\/1562903\/21\/dcph-logo-registered-rgb.jpg","datePublished":"2023-04-26T11:07:50+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/deciphera-pharmaceuticals-to-announce-first-quarter-2023-financial-results-and-host-conference-call-and-webcast-on-may-3-2023\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/deciphera-pharmaceuticals-to-announce-first-quarter-2023-financial-results-and-host-conference-call-and-webcast-on-may-3-2023\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/deciphera-pharmaceuticals-to-announce-first-quarter-2023-financial-results-and-host-conference-call-and-webcast-on-may-3-2023\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20230426005051\/en\/1562903\/21\/dcph-logo-registered-rgb.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20230426005051\/en\/1562903\/21\/dcph-logo-registered-rgb.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/deciphera-pharmaceuticals-to-announce-first-quarter-2023-financial-results-and-host-conference-call-and-webcast-on-may-3-2023\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Deciphera Pharmaceuticals to Announce First Quarter 2023 Financial Results and Host Conference Call and Webcast on May 3, 2023"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/56234","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=56234"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/56234\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=56234"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=56234"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=56234"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}